CIK 0002012593 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Rapport Therapeutics, Inc.
Sign in to watch- Ticker
- RAPP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880724208
- Phone
- 857-321-8020
- Business address
- 99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
- Former names
- Rapport Therapeutics, Inc.
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 44,032 shares at an average $24.52 ($1,079,575)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 4 Conversion 10% owner acquired 3,728,738 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion 10% owner acquired 7,520,667 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 558,824 shares at $17.00 ($9,500,008)
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change
Page 11 of 13 · 253 filings